HOWL
Werewolf Therapeutics, Inc. · Healthcare
Director Luke Evnin sold $155K of Werewolf Therapeutics, Inc.
Sold$154,525
$0.75Price
205,911Shares
−10%Stake
What HOWL did after the filing
- The stock from Thu, Apr 30 open, $0.69
- −44.6%
- S&P 500, same days
- +3.8%
Measured over 30 trading days, to the Jun 12 close.
Traded Mon, Apr 27. Filed Wed, Apr 29, 7:16 PM ET, after the close. Returns use the Apr 30 open and the Jun 12 close. Not investment advice.